{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-002072","form_type":"8-K","ticker":"CTNM","cik":"0001855175","company_name":"Contineum Therapeutics, Inc.","filed_at":"2026-01-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.560145+00:00","generated_at":"2026-05-16T08:03:18.654474+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Contineum Therapeutics approves 2026 Inducement Plan with 750,000 share reserve","bullets":["Board approved 2026 Employment Inducement Equity Incentive Plan on January 23, 2026.","Plan reserves 750,000 shares of Class A common stock for awards to new employees as inducement material.","Adopted without stockholder approval under Nasdaq Rule 5635(c)(4); no incentive stock options allowed.","Substantially similar to existing 2024 Equity Incentive Plan except for ISO prohibition and eligible recipients."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-002072","json":"https://secwatch.observer/filing/0001437749-26-002072.json","markdown":"https://secwatch.observer/filing/0001437749-26-002072.md","text":"https://secwatch.observer/filing/0001437749-26-002072.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855175/000143774926002072/0001437749-26-002072-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855175/000143774926002072/ctnm20260121_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T08:03:18.654474+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}